Sequential Revenue Growth
Second quarter 2025 revenue increased 16% sequentially from last quarter, driven by expansion of the Direct Patient Services segment and international business development initiatives.
Double-Digit Revenue Increase in Direct Patient Services
Revenue from Direct Patient Services was $3.5 million for Q2 2025, marking an increase of 12% compared to Q2 2024, driven by the Rhode Island acquisition and new operations in Puebla, Mexico.
Strong Adjusted EBITDA Growth
Q2 2025 adjusted EBITDA came in at $1.7 million compared to $949,000 in Q1 2025, showing strong cost controls and reliance on treatment volumes for growth.
Successful Expansion in International Markets
The international segment is a significant growth area with centers in Peru, Ecuador, Puebla, and a new center planned in Guadalajara, Mexico.
Strategic Partnerships and Staffing Achievements
Secured professional services agreement with Brown University Health and recruited three radiation oncologists for Rhode Island centers.